Evidence map›Paper›PMID 16775003›Full record

ArticleMolecular biology of the cell2006

Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic met receptor.

Kathleen Mood, Caroline Saucier, Yong-Sik Bong, Hyun-Shik Lee, Morag Park, Ira O Daar

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Spindle Cell Tumors with aInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. AberrantCells · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Kathleen MoodLaboratory of Protein Dynamics and Signaling, National Cancer Institute-Frederick, Frederick, MD 21702, USA.
Caroline Saucier
Yong-Sik Bong
Hyun-Shik Lee
Morag Park
Ira O Daar
National Cancer Institute · USMcGill University Health Centre · CAMolecular Oncology (United States) · US

Funding

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling PathwaysZIABC010006 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DAAR, IRA · 2009 to 2025
$11.5M
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling PathwaysZ01BC010006 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DAAR, IRA OWEN · 1996 to 2008
$1.8M
Intramural NIH HHS
6 · The paper itself

Abstract

We have shown previously that either Grb2- or Shc-mediated signaling from the oncogenic Met receptor Tpr-Met is sufficient to trigger cell cycle progression in Xenopus oocytes. However, direct binding of these adaptors to Tpr-Met is dispensable, implying that another Met binding partner mediates these responses. In this study, we show that overexpression of Grb2-associated binder 1 (Gab1) promotes cell cycle progression when Tpr-Met is expressed at suboptimal levels. This response requires that Gab1 possess an intact Met-binding motif, the pleckstrin homology domain, and the binding sites for phosphatidylinositol 3-kinase and tyrosine phosphatase SHP-2, but not the Grb2 and CrkII/phospholipase Cgamma binding sites. Importantly, we establish that Gab1-mediated signals are critical for cell cycle transition promoted by the oncogenic Met and fibroblast growth factor receptors, but not by progesterone, the natural inducer of cell cycle transition in Xenopus oocytes. Moreover, Gab1 is essential for Tpr-Met-mediated morphological transformation and proliferation of fibroblasts. This study provides the first evidence that Gab1 is a key binding partner of the Met receptor for induction of cell cycle progression, proliferation, and oncogenic morphological transformation. This study identifies Gab1 and its associated signaling partners as potential therapeutic targets to impair proliferation or transformation of cancer cells in human malignancies harboring a deregulated Met receptor.

Indexed as

Cell CycleCell Transformation, NeoplasticAdaptor Proteins, Signal TransducingAmino Acid SequenceAnimalsBinding SitesCell ProliferationCells, CulturedConserved SequenceEnzyme ActivationFibroblastsHumansIntracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein KinasesMolecular Sequence DataAdaptor Proteins, Signal TransducingGab1 protein, mouseIntracellular Signaling Peptides and ProteinsJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein KinasesOncogene Protein tpr-metPhosphatidylinositol 3-KinasesPhosphoproteinsProgesteroneProtein Tyrosine Phosphatase, Non-Receptor Type 11Protein Tyrosine PhosphatasesProto-Oncogene Proteins c-metPTPN11 protein, humanPtpn11 protein, mouseReceptors, Fibroblast Growth Factor

Identifiers

PMID16775003
PMCPMC1556377
OpenAlexW2146545679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.